Indeed, entity-overlapping mutations were exclusively detectable in ARID1A and IDH2. In men, IDH2 mutations are linked to brain tumors and acute myeloid leukemia, while IDH1 mutations may drive tumor progression. Here, IDH2 is linked to acute myeloid leukemia.